Indication
For the treatment of Duchenne muscular dystrophy (DMD) in patients 6 years of age and older
Medicine details
- Medicine name:
- givinostat (Duvyzat)
- SMC ID:
- SMC2856
- Pharmaceutical company
- Italfarmaco
- BNF chapter
- Musculoskeletal and joint diseases
- Submission type
- Full
- Publication due date:
- 08 December 2025
- SMC meeting date:
- 04 November 2025
- Patient group submission deadline:
- TBC